Melanoma Journal Articles for November 2019

BMC Cancer

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports

Koji YoshinoTakayuki NakayamaAyumu ItoEiichi Sato & Shigehisa Kitano 

BMC Cancer volume 19, Article number: 1019 (2019) 


Cancer Research

Vitamin D-VDR signaling inhibits Wnt/beta-catenin-mediated melanoma progression and promotes anti-tumor immunity

Sathya Muralidhar, Anastasia Filia, Jérémie Nsengimana, Joanna Po?niak, Sally J. O’Shea, Joey M Diaz, Mark Harland, Juliette A. Randerson-Moor, Jörg Reichrath, Jonathan P Laye, Louise van der Weyden, David J. Adams, D.T. Bishop and Julia Newton-Bishop

DOI: 10.1158/0008-5472.CAN-18-3927


Clinical Cancer Research

Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma

Rohit Thakur, Jonathan P. Laye, Martin Lauss, Joey Mark S. Diaz, Sally Jane O’Shea, Joanna Po?niak, Anastasia Filia, Mark Harland, Joanne Gascoyne, Juliette A. Randerson-Moor, May Chan, Tracey Mell, Göran Jönsson, D. Timothy Bishop, Julia Newton-Bishop, Jennifer H. Barrett and Jérémie Nsengimana

DOI: 10.1158/1078-0432.CCR-18-3659


Cureus

Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review

Bradley D. WeaverJames R. GoodmanRandy Jensen

Published: November 13, 2019 (see history)

DOI: 10.7759/cureus.6147


Nature Communications

Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors

Matthew J. SaleEmma MinihaneNoel R. MonksRebecca GilleyFrances M. RichardsKevin P. SchifferliCourtney L. AndersenEmma J. DaviesMario Aladren VicenteEiko OzonoAleksandra MarkovetsJonathan R. DryLisa DrewVikki FlemingtonTheresa ProiaDuncan I. JodrellPaul D. Smith & Simon J. Cook 

Nature Communications volume 10, Article number: 5167 (2019)

 

doi:10.1038/s41467-019-12409-w


Dove Press

miR-124 Functions As A Melanoma Tumor Suppressor By Targeting RACK1

Authors Shen C, Hua H, Gu L, Cao S, Cai H, Yao X, Chen X

Received 28 July 2019

Accepted for publication 31 October 2019

Published 19 November 2019 Volume 2019:12 Pages 9975—9986

DOI https://doi.org/10.2147/OTT.S225120


Molecular Cancer Therapeutics

Cancer Biology and Translational Studies

Distinct Transcriptional Programming Drive Response to MAPK Inhibition in BRAFV600-Mutant Melanoma Patient-Derived Xenografts

Tianshu Feng, Javad Golji, Ailing Li, Xiamei Zhang, David A. Ruddy, Daniel P. Rakiec, Felipe C. Geyer, Jane Gu, Hui Gao, Juliet A. Williams, Darrin D. Stuart and Matthew J. Meyer

DOI: 10.1158/1535-7163.MCT-19-0028


Journal of Cell Science

Melanoma mutations modify melanocyte dynamics in coculture with keratinocytes or fibroblasts

Dubravka Škalamera, Alexander J. Stevenson, Anna Ehmann, Stephen A. Ainger, Catherine Lanagan, Richard A. Sturm, Brian Gabrielli

 

Journal of Cell Science 2019 : jcs.234716 doi: 10.1242/jcs.234716 Published 25 November 2019


British Journal of Dermatology

Epidemiology 

Clinicopathological factors associated with death from thin (? 1·00 mm) melanoma

  1. ClaesonP. BaadeS. Brown H.P. Soyer B.M. Smithers A.C. Green D.C. Whiteman K. Khosrotehrani

First published: 28 September 2019 https://doi.org/10.1111/bjd.18560


BMC Women’s Health

Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19–9: a case report and review of literature

Won Ku ChoiDong Hyun LeeDong Hyu ChoKyu Yun Jang & Kyoung Min Kim 

BMC Women’s Health volume 19, Article number: 149 (2019) 


BMC Journal for ImmunoTherapy of Cancer

Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth

Meng CaoHuaijiang YanXuan HanLing WengQin WeiXiaoyan SunWuguang LuQingyun WeiJuan YeXueting CaiChunping HuXiaoyang Yin & Peng Cao 

Journal for ImmunoTherapy of Cancer volume 7, Article number: 326 (2019) 


BMC Journal for ImmunoTherapy of Cancer

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma

Matthew J. ReilleyBrittany MorrowCasey R. AgerArthur LiuDavid S. Hong & Michael A. Curran 

Journal for ImmunoTherapy of Cancer volume 7, Article number: 323 (2019)